These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1826 related items for PubMed ID: 19167687

  • 1. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 2. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
    Chen XH, Gao L, Zhang X, Gao L, Zhang C, Kong PY, Liu H, Peng XG, Sun AH, Qi DG, Gong Y, Wang QY.
    Blood Cells Mol Dis; 2009 Feb; 43(1):98-104. PubMed ID: 19356956
    [Abstract] [Full Text] [Related]

  • 3. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [Abstract] [Full Text] [Related]

  • 4. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
    Huang XJ, Han W, Xu LP, Chen YH, Liu DH, Lu J, Chen H, Zhang YC, Jiang Q, Liu KY, Lu DP.
    Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704
    [Abstract] [Full Text] [Related]

  • 5. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X, Liu D.
    Clin Transpl; 2011 Dec; ():237-45. PubMed ID: 22755417
    [Abstract] [Full Text] [Related]

  • 6. The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis.
    Xu LP, Liu KY, Liu DH, Chen H, Han W, Chen YH, Wang Y, Huang XJ.
    Bone Marrow Transplant; 2010 Jun; 45(6):985-92. PubMed ID: 19898505
    [Abstract] [Full Text] [Related]

  • 7. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Huan C, Wei H, Yu-Hong C, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Dao-Pei L.
    Ann Med; 2008 Jun; 40(6):444-55. PubMed ID: 18608121
    [Abstract] [Full Text] [Related]

  • 8. Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Sun AH, Zeng DF, Wang QY.
    Transfus Apher Sci; 2010 Aug; 43(1):23-8. PubMed ID: 20554478
    [Abstract] [Full Text] [Related]

  • 9. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 10. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 10; 82(19):1306-9. PubMed ID: 12509932
    [Abstract] [Full Text] [Related]

  • 11. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F, Diyachenko G, Zabelina T, Wolschke C, Fehse B, Bacher U, Erttmann R, Kröger N, Zander AR.
    Biol Blood Marrow Transplant; 2008 Aug 10; 14(8):913-9. PubMed ID: 18640575
    [Abstract] [Full Text] [Related]

  • 12. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.
    Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Wang JZ, Gao ZY, Zhang YC, Jiang Q, Shi HX, Lu DP.
    Bone Marrow Transplant; 2006 Aug 10; 38(4):291-7. PubMed ID: 16883312
    [Abstract] [Full Text] [Related]

  • 13. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
    Dong L, Wu T, Zhang MJ, Gao ZY, Lu DP.
    Biol Blood Marrow Transplant; 2007 Dec 10; 13(12):1515-24. PubMed ID: 18022582
    [Abstract] [Full Text] [Related]

  • 14. Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia.
    Zhang C, Zhang X, Chen XH, Gao L, Gao L, Kong PY, Peng XG, Sun AH, Wang QY.
    Transfus Apher Sci; 2011 Jun 10; 44(3):249-55. PubMed ID: 21550308
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M, Theuser C, Soucek S, Hölig K, Klingebiel T, Blau W, Fauser A, Runde V, Schwinger W, Rutt C, Ehninger G.
    Haematologica; 2000 Aug 10; 85(8):839-47. PubMed ID: 10942931
    [Abstract] [Full Text] [Related]

  • 16. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Aug 10; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 17. HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome.
    Chen Y, Liu K, Xu L, Chen H, Liu D, Zhang X, Shi H, Han W, Wang Y, Zhao T, Wang J, Wang J, Huang X.
    Bone Marrow Transplant; 2010 Aug 10; 45(8):1333-9. PubMed ID: 20062100
    [Abstract] [Full Text] [Related]

  • 18. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I.
    Biol Blood Marrow Transplant; 2006 Oct 10; 12(10):1073-84. PubMed ID: 17084371
    [Abstract] [Full Text] [Related]

  • 19. Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin.
    Lamparelli T, van Lint MT, Gualandi F, Raiola AM, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Bregante S, Berisso G, Dominietto A, Di Grazia C, Bruno B, Sessarego M, Casarino L, Verdiani S, Bacigalupo A.
    Bone Marrow Transplant; 2000 Dec 10; 26(12):1305-11. PubMed ID: 11223970
    [Abstract] [Full Text] [Related]

  • 20. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
    Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P, Ringdén O.
    Bone Marrow Transplant; 2003 Jul 10; 32(2):217-23. PubMed ID: 12838288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 92.